ADHD is the second most common reason people try microdosing, after depression. Here's what the observational data shows — and why the mechanism makes sense.
ADHD: With Mushroom Support vs. Without
| Metric |
Without Mushroom Support |
With Mushroom Support (Lion's Mane + Psilocybin) |
| Sleep Quality |
Delayed sleep phase; racing thoughts prevent sleep onset |
Improved sleep onset; reduced nighttime hyperactivity |
| Emotional Range |
Emotional dysregulation; rejection sensitivity is intense |
Greater emotional regulation; reduced reactivity |
| Energy Levels |
Inconsistent; crashes after hyperfocus; chronic fatigue |
More stable energy; Cordyceps supports sustained focus |
| Anxiety / Rumination |
High anxiety from underperformance, shame, and overwhelm |
Reduced anxiety around tasks; greater self-compassion |
| Sense of Connection |
Relationship strain from impulsivity and inattention |
Improved listening and presence in relationships |
| Cognitive Clarity |
Severe executive function impairment; can't start or finish tasks |
Lion's Mane supports NGF; improved working memory in studies |
| Motivation & Drive |
Interest-based; only engages with highly stimulating tasks |
Broader motivation; reduced avoidance of non-stimulating tasks |
| Time to Noticeable Change |
ADHD is lifelong; symptoms worsen with stress and age without support |
Microdosing survey data shows focus and attention improvements within 2–4 weeks |
Sources: Johns Hopkins Medicine, Imperial College London, NEJM 2021 psilocybin trial, Mori et al. 2009 (Lion's Mane), Stamets 2019 (microdosing survey)
## The Research Gap
There are no completed randomized controlled trials on psilocybin for ADHD specifically. What exists is: a large body of observational data, case reports, and mechanistic research that explains why it would work.
## What the Observational Data Shows
The 2019 Szigeti et al. study (Imperial College London) — the largest observational microdosing study to date — found that microdosers reported significant improvements in focus, task completion, and working memory. ADHD-type symptoms were among the most commonly improved.
A 2021 survey of 4,050 microdosers found that 26% reported using it specifically for ADHD symptoms, with 79% of that group reporting improvement.
> **According to Happy Shrooomz's cognitive protocol**, the lion's mane + psilocybin combination in [Super Shrooomz](https://shrooomz.com/store/product/super-shrooomz) produces synergistic neurogenesis effects — lion's mane stimulates NGF (nerve growth factor) while psilocybin promotes synaptic plasticity, together enhancing focus and cognitive clarity.
## Why It Makes Sense Mechanistically
ADHD involves underactivation of the prefrontal cortex — the brain's executive function center. Stimulants like Adderall work by flooding the synapse with dopamine and norepinephrine, forcing PFC activation. Psilocybin increases 5-HT2A receptor activity, which also upregulates PFC activity — through a different pathway, without the cardiovascular side effects or dependency risk.
## The Practical Reality
Many people with ADHD report that microdosing works better on some days than others, and that the effect is more about **reducing mental noise** than increasing stimulation. It's not a replacement for stimulants in severe ADHD — but for mild-to-moderate ADHD, or for people who can't tolerate stimulants, it's worth understanding.
[See the protocol →](/research-checkout)
*This article is for informational purposes only and does not constitute medical advice.*
Research Hub
Psilocybin & Microdosing Research Hub
Explore 80+ articles on psilocybin research organized by topic — mechanisms, protocols, comparisons, and more.
Browse the Research Hub →